25 June 2026
Advocate General Szpunar Makes Questionable Proposal to Relax Language Requirements for Labelling of Parallel-Traded Medicinal Products
10 min read
On 11 June 2026, Advocate General Szpunar delivered his non-binding Opinion concerning the application of labelling and national language requirements under Directive 2001/83/EC “on medicinal products for human use” to parallel-imported medicinal products.
The Opinion is highly questionable and, if followed by the Court of Justice of the European Union, would mark yet another step in the gradual erosion of public health protection in favour of the free movement of parallel-traded goods.
Attached is a note discussing the Opinion.
Attachments:
Key contacts
->
News & insights
1 min
read
read
News
Court of Justice of European Union Defines Limits of Distributors’ Due Care Obligations Under Medical Devices Regulation
11 June 2026
1 min
read
read
News
Claire Simpson nominated in Women@’s “Advancement to Leadership in Law” category
9 June 2026
1 min
read
read
Briefings
The online withdrawal button: A new mandatory obligation for online traders
9 June 2026
1 min
read
read
News
Fabrizio Di Gianni to speak at the Treviso Antitrust Conference 2026
2 June 2026
3 min
read
read
News
USTR Places EU on 2026 Special 301 Watch List for Failure to Give Adequate Protection to Innovative Medicines
28 May 2026
15 min
read
read
News
VBB authors Belgium chapter of Chambers Global Practice Guide: Corporate M&A 2026
26 May 2026
5 min
read
read
News
Belgian Competition Authority Suspends Discriminatory Rules in Second Division Professional Football
12 May 2026
